Evolving therapies in neuronopathic LSDs: opportunities and challenges.

Abstract excerpt

Lysosomal storage disorders (LSD) are multisystemic progressive disorders caused by genetic mutations involving lysosomal function. While LSDs are individually considered rare diseases, the overall true prevalence of these disorders is likely higher than our current estimates. More than two third of the LSDs have associated neurodegeneration and the neurological phenotype often defines the course of the disease...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Genetic Therapy
• Share to Lysosomal Storage Diseases
• Share to Lysosomes